2022
DOI: 10.1128/spectrum.01093-22
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic Investigation of the Antibacterial Mechanism of Cefiderocol against Escherichia coli

Abstract: CFDC was the first FDA-approved siderophore cephalosporin antibiotic in 2019 and is known for its Trojan horse tactics and broad antimicrobial activity against Gram-negative bacteria. However, its antibacterial mechanism is not fully understood, and whether it has an impact on in vivo iron ion homeostasis remains unknown.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 56 publications
(49 reference statements)
0
0
0
Order By: Relevance